Literature DB >> 29031421

TLR2 activation induced by H. pylori LPS promotes the differential expression of claudin-4, -6, -7 and -9 via either STAT3 and ERK1/2 in AGS cells.

Christian O Chavarría-Velázquez1, Ana C Torres-Martínez1, Luis F Montaño1, Erika P Rendón-Huerta2.   

Abstract

Gastric carcinogenesis has been associated to H. pylori virulence factors that induce a chronic inflammation process. Lipopolysaccharides play a role in chronic inflammatory responses via TLR2- and TLR4-dependent signaling pathways. Similarly, cellular invasiveness, metastatic potential and prognosis are usually associated to claudin-4, -6, -7 and -9 expression in gastric carcinogenesis. Therefore, the aim of this study was to determine if H. pylori LPS exerts an influence on carcinogenesis-related claudin expression and if it was directly regulated through the TLR2 pathway. Human antrum gastric adenocarcinoma AGS cells exposed or not to H. pylori LPS were used. Polyclonal anti-claudin-4, -6, -7 and -9, anti-TLR2, anti-pERK1/2 as well as rabbit monoclonal anti-pNFκB p65 and mouse monoclonal anti-CdX2 were used. ERK1/2 inhibitor UO126 and STAT3 inhibitor Stattic were also used. Western blot, immunofluorescence and confocal experiments were performed in whole cells as well as total protein, nuclear and cell membrane fractions. The results showed that H. pylori LPS increased the expression of TLR2 in a time dependent bi-phasic manner (<12 and >12h exposure). Immunofluorescence using AGS monolayers corroborated the double phase TLR2 expression mainly on the cell membrane but a detectable signal was also determined in the cytoplasm of the cells. Activation of NFkB was downstream and depended on TLR2 expression as a statistically significant increase in pNFkB, that followed a pattern highly similar to the TLR2 expression was observed on the cell membrane fraction. The increase in TLR2 expression was accompanied by dramatically increased claudin-4 expression in cultures exposed from 30m to 8h to LPS. Increased expression of claudin-6, -7 and -9 also increases in >12h LPS exposure times. The increase in claudins expression was also dependent on NFkB activation. The results also showed an increase in pSTAT3 that followed a bi-phasic pattern that began 30min after stimulation and was compatible with the increase in TLR2 expression. The expression of the claudin-4 related CDX2 transcription factor did not followed the biphasic pattern. The results also showed that claudin-4 expression was STAT3 dependent whereas claudin-6, 7 and 9 expressions was ERK1/2 dependent. Our results suggest that H. pylori LPS induces TLR2 expression in the AGS cells, and that the longer the exposure to LPS, the greater the expression of TLR2 in the cell membrane. Consequently the expression of claudin-4, -6, -7 and -9 also increases.
Copyright © 2017 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Claudins; ERK1/2; Helicobacter pylori; Lipopolysaccharide; STAT3; Toll-like receptors

Mesh:

Substances:

Year:  2017        PMID: 29031421     DOI: 10.1016/j.imbio.2017.10.016

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  10 in total

1.  NZO/HlLtJ as a novel model for the studies on the role of metabolic syndrome in acute radiation toxicity.

Authors:  Laura E Ewing; Isabelle R Miousse; Rupak Pathak; Charles M Skinner; Stanley Kosanke; Marjan Boerma; Martin Hauer-Jensen; Igor Koturbash
Journal:  Int J Radiat Biol       Date:  2019-01-14       Impact factor: 2.694

2.  Expanded Expression of Toll-Like Receptor 2 in Proliferative Verrucous Leukoplakia.

Authors:  Joon Koh; Zoya B Kurago
Journal:  Head Neck Pathol       Date:  2019-03-19

3.  Impact of miR-223-3p and miR-2909 on inflammatory factors IL-6, IL-1ß, and TNF-α, and the TLR4/TLR2/NF-κB/STAT3 signaling pathway induced by lipopolysaccharide in human adipose stem cells.

Authors:  Juan Wu; Ping Niu; Yueqiang Zhao; Yanyang Cheng; Weiping Chen; Lan Lin; Jingmei Lu; Xue Cheng; Zhiliang Xu
Journal:  PLoS One       Date:  2019-02-26       Impact factor: 3.240

4.  The Helicobacter pylori Urease Virulence Factor Is Required for the Induction of Hypoxia-Induced Factor-1α in Gastric Cells.

Authors:  Manuel Valenzuela-Valderrama; Paulina Cerda-Opazo; Steffen Backert; María Fernanda González; Nicolás Carrasco-Véliz; Carla Jorquera-Cordero; Sergio Wehinger; Jimena Canales; Denisse Bravo; Andrew F G Quest
Journal:  Cancers (Basel)       Date:  2019-06-10       Impact factor: 6.639

5.  Weak Agonistic LPS Restores Intestinal Immune Homeostasis.

Authors:  Alex Steimle; Lena Michaelis; Flaviana Di Lorenzo; Thorsten Kliem; Tobias Münzner; Jan Kevin Maerz; Andrea Schäfer; Anna Lange; Raphael Parusel; Kerstin Gronbach; Kerstin Fuchs; Alba Silipo; Hasan Halit Öz; Bernd J Pichler; Ingo B Autenrieth; Antonio Molinaro; Julia-Stefanie Frick
Journal:  Mol Ther       Date:  2019-07-19       Impact factor: 11.454

Review 6.  Molecular anatomy and pathogenic actions of Helicobacter pylori CagA that underpin gastric carcinogenesis.

Authors:  Atsushi Takahashi-Kanemitsu; Christopher T Knight; Masanori Hatakeyama
Journal:  Cell Mol Immunol       Date:  2019-12-05       Impact factor: 11.530

Review 7.  Helicobacter pylori Virulence Factors-Mechanisms of Bacterial Pathogenicity in the Gastric Microenvironment.

Authors:  Jacek Baj; Alicja Forma; Monika Sitarz; Piero Portincasa; Gabriella Garruti; Danuta Krasowska; Ryszard Maciejewski
Journal:  Cells       Date:  2020-12-25       Impact factor: 6.600

8.  Effects of Black Ginseng Water Extract under the Inflammatory Conditions of Cultured Sebocytes and Outer Root Sheath Cells.

Authors:  Jun Young Kim; Mi Hee Kwack; Eun Hye Lee; Weon Ju Lee
Journal:  Ann Dermatol       Date:  2022-03-24       Impact factor: 1.444

Review 9.  Inflammatory Response to Different Toxins in Experimental Sepsis Models.

Authors:  Kayle Dickson; Christian Lehmann
Journal:  Int J Mol Sci       Date:  2019-09-05       Impact factor: 5.923

10.  Clostridium perfringens enterotoxin induces claudin-4 to activate YAP in oral squamous cell carcinomas.

Authors:  Chie Nakashima; Kazuhiko Yamamoto; Shingo Kishi; Takamitsu Sasaki; Hitoshi Ohmori; Rina Fujiwara-Tani; Shiori Mori; Isao Kawahara; Yukiko Nishiguchi; Takuya Mori; Masuo Kondoh; Yi Luo; Tadaaki Kirita; Hiroki Kuniyasu
Journal:  Oncotarget       Date:  2020-01-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.